HOME >> BIOLOGY >> NEWS
Embryo project investigates agents of change in science

TEMPE, Ariz. -- An ambitious group of historians, philosophers, bioethicists, scientists, lawyers and policy experts from ASU will be taking a detailed look at the history of embryo research in order to understand how society, culture and technology have affected the course of science.

ASU professor Jane Maienschein and her colleagues have been awarded a three-year grant of $750,000 by the National Science Foundation for the project as a part of the NSF Human and Social Dynamics program.

Maienschein, director of ASU's Center for Biology and Society, will lead a diverse group of researchers in examining how the study of embryos has developed, especially from the 19th century to the present. Research leaders in the project are all members of ASU's School of Life Sciences and include professors Manfred Laubichler; Gary Marchant, director of the Center for Law, Science and Technology; and Daniel Sarewitz, director of the Consortium for Science, Policy and Outcomes.

Under the "embryo project," Maienschein and her ASU collaborators have assembled a group of undergraduate and graduate researchers, who will work with two dozen investigators from six countries to examine the different scientific, social, cultural and organizational contexts that have affected the development of embryology as a science.

"Embryo research serves as an ideal candidate to investigate the intersection of biology and society," Maienschein said. Stem cell research, a recent development in the study of embryos, provides a good example of how ethical, legal, political and religious factors can affect science and its role in society.

Goals for the project include providing a rich description of embryo research over key periods of its history, analyzing and comparing each period for agents of change and "developing materials for scholars and the general public to address any questions related to embryo research," Maienschein said.

In
'"/>

Contact: Skip Derra
skip.derra@asu.edu
480-965-4823
Arizona State University
18-Oct-2006


Page: 1 2

Related biology news :

1. Embryonic selection of sex avoids conceiving blind children
2. Embryonic stem cells do better on bumpy nanoscale mattress
3. Embryonic patterning makes the feathers fly
4. Embryo fossils reveal animal complexity 10 million years before Cambrian Explosion
5. Embryo tests give parents the choice
6. AAAS urges US President to sign Embryonic Stem Cell Act
7. Embryos exposed in 3-D
8. Embryos tell story of Earths earliest animals
9. Embryonic stem cells accrue genetic changes
10. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
11. Embryonic law and order

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Embryo project investigates agents change science

(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: